Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

Hydrazine

Base Information Edit
  • Chemical Name:Hydrazine
  • CAS No.:302-01-2
  • Deprecated CAS:119775-10-9,31886-26-7,75013-58-0,78206-91-4,31886-26-7,75013-58-0
  • Molecular Formula:H4N2
  • Molecular Weight:32.0452
  • Hs Code.:28251090
  • European Community (EC) Number:206-114-9
  • ICSC Number:0281
  • UN Number:2029,3293,2030
  • UNII:27RFH0GB4R
  • DSSTox Substance ID:DTXSID3020702
  • Nikkaji Number:J1.811.009A,J1.516D
  • Wikipedia:Hydrazine
  • Wikidata:Q58447,Q27110398
  • NCI Thesaurus Code:C29097
  • ChEMBL ID:CHEMBL1237174
  • Mol file:302-01-2.mol
Hydrazine

Synonyms:hydrazine;hydrazine dihydrochloride;hydrazine hydrate;hydrazine monohydrate;hydrazine mononitrate;hydrazine nitrate;hydrazine phosphate (1:1);hydrazine phosphate (2:1);hydrazine sulfate;hydrazine sulfate (1:1) monosodium salt;hydrazine sulfate (2:1);hydrazine tartrate;segidrin

Suppliers and Price of Hydrazine
Supply Marketing:Edit
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • Sigma-Aldrich
  • Hydrazine anhydrous, 98%
  • 50g
  • $ 118.00
  • Sigma-Aldrich
  • Hydrazine solution 35 wt. % in H2O
  • 500g
  • $ 115.00
  • Sigma-Aldrich
  • Hydrazine solution 1 M in acetonitrile
  • 800ml
  • $ 1550.00
  • Sigma-Aldrich
  • Hydrazine solution 35 wt. % in H2O
  • 100g
  • $ 48.10
  • Sigma-Aldrich
  • Hydrazine solution 35 wt. % in H2O
  • 5g
  • $ 39.90
  • Sigma-Aldrich
  • Hydrazine solution 1.0 M in THF
  • 100ml
  • $ 54.90
  • Sigma-Aldrich
  • Hydrazine solution 1 M in acetonitrile
  • 100ml
  • $ 353.00
  • Sigma-Aldrich
  • Hydrazine anhydrous, 98%
  • 100g
  • $ 205.00
  • Sigma-Aldrich
  • Hydrazine solution 1.0 M in THF
  • 800ml
  • $ 144.00
  • GFS CHEMICALS
  • HYDRAZINE,35%SOLUTION
  • 500 ML
  • $ 119.68
Total 0 raw suppliers
Chemical Property of Hydrazine Edit
Chemical Property:
  • Appearance/Colour:COLOURLESS FUMING AND HYGROSCOPIC LIQUID 
  • Vapor Pressure:5 mm Hg ( 25 °C) 
  • Melting Point:1,4°C 
  • Refractive Index:n20/D 1.47(lit.) 
  • Boiling Point:113.5 °C at 760 mmHg 
  • PKA:pK1 (25°): ~6.05 
  • Flash Point:-4 °F 
  • PSA:52.04000 
  • Density:1.011 
  • LogP:0.21940 
  • Storage Temp.:2-8°C 
  • Water Solubility.:miscible 
  • XLogP3:-1.5
  • Hydrogen Bond Donor Count:2
  • Hydrogen Bond Acceptor Count:2
  • Rotatable Bond Count:0
  • Exact Mass:32.037448136
  • Heavy Atom Count:2
  • Complexity:0
  • Transport DOT Label:Corrosive Flammable Liquid Poison,Poison
Purity/Quality:

Hydrazine anhydrous, 98% *data from reagent suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes:T,N,F 
  • Statements: 45-23/24/25-34-43-50/53-10-51/53-36/37/38-20/21/22-19-11-36/38 
  • Safety Statements: 53-26-36/37-45-61-60-36/37/39-16 
MSDS Files:

SDS file from LookChem

Total 1 MSDS from other Authors

Useful:
  • Chemical Classes:Nitrogen Compounds -> Hydrazines
  • Canonical SMILES:NN
  • Inhalation Risk:A harmful contamination of the air can be reached very quickly on evaporation of this substance at 20 °C.
  • Effects of Short Term Exposure:The substance is corrosive to the eyes, skin and respiratory tract. Inhalation may cause lung oedema, but only after initial corrosive effects on eyes and/or airways have become manifest. Corrosive on ingestion. The substance may cause effects on the liver and central nervous system. Exposure could cause death.
  • Effects of Long Term Exposure:Repeated or prolonged contact may cause skin sensitization. The substance may have effects on the liver, kidneys and central nervous system. This substance is possibly carcinogenic to humans.
  • Uses Hydrazine is mostlyed used as a blowing agent in preparing polymer foams. It is mainly used as rocket fuels, boiler water treatments, chemical reactants, medicines, and in cancer research. Hydrazine is used as a high-energy rocket fuel, as a reducing agent, and for preparing organic hydrazine derivatives. The propellant grade of commercial hydrazine is more than 97.7% active. It is also used as an oxygen scavenger in boiler water. Hydrazine has also been used as an experimental drug for treating tuberculosis and sickle cell anemia. Reducing agent for many transition metals and some nonmetals (arsenic, selenium, tellurium), as well as uranium and plutonium; corrosion inhibitor in boiler feedwater and reactor cooling water; waste water treatment; electrolytic plating of metals on glas Hydrazine is a highly reactive base and powerful reducing agent. It acts as an oxygen scavenger and is highly reactive with other chemicals. Hydrazine has a number of uses including, as a chemical precursor to blowing agents (e.g., azodicarbonamide and azobisisobutyronitrile), in the organic synthesis of pharmaceuticals and pesticides (e.g., isoniazid, fluconazole, and 3-amino-1,2,4-triazole), as a missile and rocket propellant (e.g., used in the F-16 fighter), as a gas-forming agent in air bags (e.g., sodium nitrite), as a corrosion inhibitor and reducing agent in large industrial boilers, and as a fuel source in fuel cells.
  • Description Hydrazine sulphate, hydrobromide and hydrochloride have been reported to be occupational sensitizers, mainly in soldering flux.
  • Physical properties Colorless, mobile, fuming liquid; ammoniacal odor; density 1.0045 g/mL at25°C; refractive index 1.46044 at 22°C; solidifies at 2°C to a white crystallinesolid; boils at 113.5°C; flash point 52°C; burns with a violet flame; vapor pres-sure 14.4 torr at 25°C; critical temperature 379.85°C; critical pressure 145atm; surface tension 66.67 dyne/cm at 25°C; dielectric constant 51.7 at 25°C;viscosity 0.876 centipoise at 25°C; very soluble in water; forms an azeotropewith water at molar composition of 58.5% hydrazine: 41.5% water (71.48%:28.52% by weight), the azeotrope with water boils at 120.5°C; forms hydrazinehydrate at 1:1 molar concentration in water; soluble in alcohols and other polar solvents; pKa 8.1 at 25°C.
Technology Process of Hydrazine

There total 565 articles about Hydrazine which guide to synthetic route it. The literature collected by LookChem mainly comes from the sharing of users and the free literature resources found by Internet computing technology. We keep the original model of the professional version of literature to make it easier and faster for users to retrieve and use. At the same time, we analyze and calculate the most feasible synthesis route with the highest yield for your reference as below:

synthetic route:
Guidance literature:
In dichloromethane; Electrochem. Process; electrocatalytic redn. at Fe(III)(PP)Cl-modified electrode, pH 2.1, -0.8 V, 1.0 h;
Guidance literature:
With potassium graphite; C30H51ClNOP2V; In diethyl ether; at -78 - 20 ℃; for 1.33333h; under 760.051 Torr; Reagent/catalyst; Schlenk technique;
DOI:10.1002/anie.201802310
Refernces Edit

Ruthenium complexes bearing N-H acidic pyrazole ligands

10.1002/ejic.201000802

The study focuses on the synthesis and investigation of ruthenium complexes bearing N-H acidic pyrazole ligands and their application in catalytic hydrogenation reactions. The researchers treated chelate ligands containing pyrazole groups with various ruthenium precursors to form complexes with protic N-H groups near the catalytically active ruthenium center. These complexes were characterized by spectroscopic methods and DFT calculations, and their structure and reactivity were analyzed. The study aimed to understand the role of the acidic N-H groups in metal-ligand-bifunctional hydrogenation, where a hydrido ligand and a proton from a protic group are transferred simultaneously. The catalytic performance of these complexes was evaluated through the hydrogenation and transfer hydrogenation of acetophenone, and the results were connected to the ligand's electronic and structural properties. The research provides insights into the design of efficient catalysts for hydrogenation reactions by leveraging the acidic N-H groups in pyrazole ligands.

The conversion of isothiazoles into pyrazoles using hydrazine

10.1016/j.tet.2009.06.041

The research focuses on the chemical conversion of isothiazoles into pyrazoles using hydrazine as the primary reactant. The study explores the influence of various substituents at the C-3, C-4, and C-5 positions of the isothiazole ring on the ring transformation process and identifies limitations of this conversion. Experiments involve treating isothiazoles with anhydrous hydrazine, either neat or in combination with co-solvents like DMF or DMSO, and examining the products formed under different conditions, such as temperature and reaction time. The analyses used to characterize the products include techniques like thin-layer chromatography (TLC), melting point determination, UV-Vis spectroscopy, infrared (IR) spectroscopy, nuclear magnetic resonance (NMR) spectroscopy, and mass spectrometry (EI), which collectively provide a comprehensive evaluation of the reaction outcomes and the structural features of the synthesized pyrazole compounds.

Expedient synthesis of a novel class of pseudoaromatic amino acids: Tetrahydroindazol-3-yl- and tetrahydrobenzisoxazol-3-ylalanine derivatives

10.1016/j.tetlet.2003.11.133

The study presents a concise synthesis method for a novel class of homochiral aromatic amino acid surrogates, featuring tetrahydroindazole or benzisoxazole systems. These surrogates were synthesized through the acylation of cyclic 1,3-diketone by the side-chain carboxyl functionality of specific amino acid precursors, followed by a regioselective condensation with hydrazine, N-benzylhydrazine, and hydroxylamine. The synthetic strategy is versatile, allowing for the creation of structurally diverse derivatives. These novel amino acids can be efficiently incorporated into proteins and have potential applications in imparting unique properties to biological peptides. The study also includes the synthesis of Na-Fmoc-protected derivatives, which are useful for solid-phase peptide assembly, and the exploration of the stereochemistry integrity of the homochiral starting material through chemical transformations. The synthesized amino acids offer opportunities as structural surrogates of tryptophan and as building blocks for designing molecular probes.

Ag(I)-catalyzed regioselective ring-opening of N -tosylaziridine and N -tosylazetidine with S -, O -, and N -nucleophiles and tethered dinucleophiles

10.1021/jo102285z

The research focuses on the Ag(I)-catalyzed regioselective ring-opening of N-tosylaziridines and N-tosylazetidines with various S-, O-, and N-nucleophiles, as well as tethered dinucleophiles. The experiments utilized [Ag(COD)2]PF6 as a catalyst to facilitate the ring-opening reactions with nucleophiles such as alcohols, amines, thiols, and related 1,2-ethane dinucleophiles. Initial rate studies and DFT-based evaluations of stepwise energetics were conducted to understand the relationship between nucleophilic reactivity and binding affinity to cationic Ag(I). The study suggests an inverse relationship between the nucleophilic reactivity of a heteroatom donor and its binding affinity to cationic Ag(I). The analysis involved monitoring reactions using 1H NMR, and the products were purified and characterized using column chromatography and NMR spectroscopy. The research also explored the substrate scope and functional group selectivity, yielding a range of 1,2-amino ethers, diamines, amino thioethers, and 1,3-amino ethers in good to excellent yields.

Synthesis and antiplatelet activity of ethyl 4-(1-benzyl-1H-indazol-3-yl)benzoate (YD-3) derivatives

10.1016/j.bmc.2007.10.070

The research focuses on the synthesis and antiplatelet activity of ethyl 4-(1-benzyl-1H-indazol-3-yl)benzoate (YD-3) derivatives. The main objective was to develop novel anti-PAR4 (protease-activated receptor 4) agents by synthesizing a series of YD-3 derivatives and evaluating their selective anti-PAR4 activity. The study involved a structure–activity relationship (SAR) analysis to identify key functional groups contributing to the anti-PAR4 activity. The experiments included the synthesis of various YD-3 derivatives through chemical reactions using reagents such as Et3N, CHCl3, HCl, NH2NH2, Pd/C, and EtOH, among others. The synthesized compounds were then tested for their ability to inhibit platelet aggregation, ATP release, and P-selectin expression, which are critical factors in arterial thrombosis. The analyses used included melting point determination, IR spectroscopy, NMR spectroscopy, MS spectrometry, UV spectrophotometry, and elemental analysis to characterize the compounds. The antiplatelet activity was assessed by measuring the inhibition of platelet aggregation induced by various agents such as U46619, collagen, thrombin, SFLLRN, and GYPGKF. Additionally, the release of ATP and expression of P-selectin were measured to evaluate the effect of the compounds on platelet granule secretion. The findings from these experiments were used to establish guidelines for the development of new antithrombotic drugs.

Benzodipyrandiones double fused with pyrimidine and pyrazole

10.1002/ardp.19853180215

The research focuses on the synthesis and investigation of pyran derivatives, specifically benzodipyrandiones that are double fused with pyrimidine and pyrazole. The purpose of the study was to explore the chemical reactions and properties of these complex organic compounds. The researchers started with the Kostanecki method to synthesize benzodi-pyrandion from diacetylresorcin, which was then hydrolyzed to form a tetraketon. This intermediate reacted with CS2/KOH/DMS to yield 2,8-bisdimethylthiobenzodipyrandion, which was further transformed into various derivatives through reactions with piperidine, hydrazine, and benzamidin. The resulting compounds, including 3,7-diphenyl-benzo[1,2-b:5,4-b']di(pyrano[2,3-c]pyrazol)-4,6-dion, 4,8-diphenyl-benzo[1,2-b:5,4-b']di(pyrano[2,3-d]pyrimidin)-5,7-dion, and 3,7-Dibenzoyl-2,8-dipiperidino-benzo[1,2-b:5,4-b']dipyran-1,6-dion, were found to be poorly soluble in common solvents. The study concluded with the characterization of these compounds through melting point determination, yield calculation, and spectroscopic analysis, including infrared (IR) and proton nuclear magnetic resonance (1H-NMR) spectroscopy. The chemicals used in the process included diacetylresorcin, CS2, KOH, DMS, piperidine, hydrazine, benzamidin, and various solvents such as DMSO, aceton, and ethanol.

Synthesis and pharmacologic study of pyridazino[4,5-b]carbazoles

10.1248/cpb.37.2679

The research focused on the synthesis and pharmacological evaluation of pyridazino[4,5-b]carbazoles, a class of heterocyclic compounds with potential antineoplastic properties. The purpose of the study was to create and test these compounds for their cytotoxic activity against L1210 leukemia in mice. The synthesis involved a cyclization reaction of hydrazine with carbazole-2,3-methyl dicarboxylates to form 1,4-dioxo-1,2,3,4-tetrahydro-pyridazino[4,5-b]carbazoles. Further chemical manipulations, such as chlorodehydroxylation and nucleophilic substitution, led to the formation of 1,4-dichloropyridazino[4,5-b]carbazoles and 1,4-dialkoxy pyridazino[4,5-b]carbazoles. Despite efforts to improve solubility for pharmacological testing through chemical modifications, the tested compounds did not show significant cytotoxic activity. The chemicals used in the process included various carbazole derivatives, hydrazine, phosphorus oxychloride, and alkoxides like sodium methoxide and sodium ethoxide. The conclusions were that the synthesized pyridazino[4,5-b]carbazoles lacked significant antitumor activity in vivo, possibly due to insufficient solubility of the tested substances.

Post RFQ for Price